PLSE - Pulse Biosciences, Inc. Market Value

Current price action for Pulse Biosciences, Inc. (PLSE) shows figures at 4.17. Pulse Biosciences, Inc. (PLSE) is developing a closed nanosecond pulse environment via the CellFX platform, creating barriers to prevent clinics from switching to alternatives. The business relies on the development of ablation systems, awaiting an FDA verdict and the completion of cardiology tests amid high R&D expenditures. Meanwhile, the growth strategy incorporates ESG standards by reducing plastic in production.

Pulse Biosciences Inc - PLSE Market Value (period 07/04/2022 - 11/12/2026)

Comprehensive metric breakdowns and analytics for Pulse Medical (PLSE)

- market price and analyst price targets:

Price Chart Pulse Biosciences|PLSE - Price Target Chart

- market capitalization statistics:

Market Value Pulse Medical|PLSE - Company Buyout Price

- book value of equity indicators:

Book Value per Share Pulse Biosciences|PLSE - Total Stockholders' Equity|Market Cap to Net Assets Ratio pulsebiosciences.com|PLSE - Aggregate Business Assets

- company liabilities and liquidity data:

Total Debt to Capital Pulse Biosciences, Inc.|PLSE - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Pulse Biosciences, Inc.|PLSE - Company Cumulative Debt|Debt to Book Capitalization Ratio Pulse Medical|PLSE - Company Long-Term Loans and Borrowings|Company Short-Term Debts Pulse Biosciences|Quick Liquidity pulsebiosciences.com

- financial results and valuation multiples details:

PLSE - Profit After Tax|Projected Future Earnings Pulse Biosciences, Inc.|PLSE - Market Cap to Earnings|Projected Price to Earnings Pulse Corp|PLSE - PEG Multiple|Enterprise Value to EBITDA Ratio Pulse Medical|PLSE - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Pulse Biosciences|PLSE - Net earnings per share for the last four quarters|Quarterly EPS earnings growth pulsebiosciences.com|PLSE - Net earnings per share growth this year|Expected earnings per share growth for next year Pulse Biosciences, Inc.

Initial company analysis:PLSE (Pulse Biosciences)

Market capitalization, calculated as the product of the current share price and the total number of outstanding securities, determines the aggregate value of the business in the eyes of investors. An analysis of the stock market valuation of Pulse Biosciences, Inc. (PLSE) allows for tracking how geopolitical instability and sanction restrictions hindering the export of medical systems adjust the enterprise's market value in real-time.

Key competitors